Ulcerative Colitis Therapeutics Market : Size, Growth, Share, Trends, Competitive Landscape, Forecast To 2035
The global ulcerative colitis therapeutics market is projected to be worth USD 7.2 billion in 2025 and is expected to expand at a CAGR of 5.1%, reaching USD 11.9 billion by 2035, according to Fact.MR. Ulcerative colitis is a chronic form of inflammatory bowel disease (IBD) characterized by inflammation and ulceration in the colon and rectum. In 2024, the market experienced notable...
0 Comments 0 Shares 123 Views 0 Reviews